# Old Second Bancorp Inc: financial statements, quarterly

OSBC · Nasdaq · CIK 357173 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/osbc.md) · [Financials](/companies/osbc/financials.md) · [Filings](/companies/osbc/filings.md) · [Insiders](/companies/osbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/osbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [11.2](/filings/0000357173-24-000075.md) | [12.5 d](/filings/0001558370-25-002383.md) | [13.5](/filings/0000357173-25-000035.md) | [13.5](/filings/0000357173-24-000059.md) | [15.5](/filings/0000357173-24-000075.md) | [13.7 d](/filings/0001558370-25-002383.md) | [10.7](/filings/0000357173-25-000035.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.1](/filings/0000357173-24-000075.md) | [6.7 d](/filings/0001104659-26-020393.md) | [7.2](/filings/0000357173-25-000035.md) | [7.3](/filings/0000357173-25-000076.md) | [6.9](/filings/0000357173-25-000091.md) | [6.3 d](/filings/0001104659-26-020393.md) | [6.4](/filings/0000357173-26-000022.md) | [7.4](/filings/0000357173-26-000045.md) | [3.2](/filings/0000357173-25-000091.md) | [10.5 d](/filings/0001104659-26-020393.md) | [8.5](/filings/0000357173-26-000022.md) | [9.7](/filings/0000357173-26-000045.md) |
| Net income | $m | [24.3](/filings/0000357173-24-000075.md) | [18.2 d](/filings/0001104659-26-020393.md) | [21.3](/filings/0000357173-25-000035.md) | [21.9](/filings/0000357173-25-000076.md) | [23.0](/filings/0000357173-25-000091.md) | [19.1 d](/filings/0001104659-26-020393.md) | [19.8](/filings/0000357173-26-000022.md) | [21.8](/filings/0000357173-26-000045.md) | [9.9](/filings/0000357173-25-000091.md) | [28.8 d](/filings/0001104659-26-020393.md) | [25.6](/filings/0000357173-26-000022.md) | [28.2](/filings/0000357173-26-000045.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000357173-24-000075.md) | not reported | [0.47](/filings/0000357173-25-000035.md) | [0.48](/filings/0000357173-25-000076.md) | [0.50](/filings/0000357173-25-000091.md) | not reported | [0.43](/filings/0000357173-26-000022.md) | [0.48](/filings/0000357173-26-000045.md) | [0.18](/filings/0000357173-25-000091.md) | not reported | [0.48](/filings/0000357173-26-000022.md) | [0.54](/filings/0000357173-26-000045.md) |
| Basic EPS | $ per share | [0.55](/filings/0000357173-24-000075.md) | not reported | [0.48](/filings/0000357173-25-000035.md) | [0.48](/filings/0000357173-25-000076.md) | [0.52](/filings/0000357173-25-000091.md) | not reported | [0.44](/filings/0000357173-26-000022.md) | [0.49](/filings/0000357173-26-000045.md) | [0.19](/filings/0000357173-25-000091.md) | not reported | [0.49](/filings/0000357173-26-000022.md) | [0.55](/filings/0000357173-26-000045.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [109](/filings/0000357173-23-000085.md) | [100](/filings/0001558370-25-002383.md) | [98.1](/filings/0000357173-24-000035.md) | [121](/filings/0000357173-24-000059.md) | [116](/filings/0000357173-24-000075.md) | [99.3](/filings/0001104659-26-020393.md) | [256](/filings/0000357173-25-000035.md) | [142](/filings/0000357173-25-000076.md) | [117](/filings/0000357173-25-000091.md) | [124](/filings/0000357173-26-000045.md) | [116](/filings/0000357173-26-000022.md) | [143](/filings/0000357173-26-000045.md) |
| Total assets | $m | [5,758](/filings/0000357173-23-000085.md) | [5,723](/filings/0001558370-25-002383.md) | [5,616](/filings/0000357173-24-000035.md) | [5,663](/filings/0000357173-24-000059.md) | [5,672](/filings/0000357173-24-000075.md) | [5,649](/filings/0001104659-26-020393.md) | [5,728](/filings/0000357173-25-000035.md) | [5,701](/filings/0000357173-25-000076.md) | [6,992](/filings/0000357173-25-000091.md) | [6,903](/filings/0000357173-26-000045.md) | [6,849](/filings/0000357173-26-000022.md) | [6,870](/filings/0000357173-26-000045.md) |
| Total liabilities | $m | [5,226](/filings/0000357173-23-000085.md) | [5,146](/filings/0001558370-25-002383.md) | [5,020](/filings/0000357173-24-000035.md) | [5,043](/filings/0000357173-24-000059.md) | [5,010](/filings/0000357173-24-000075.md) | [4,978](/filings/0001104659-26-020393.md) | [5,033](/filings/0000357173-25-000035.md) | [4,983](/filings/0000357173-25-000076.md) | [6,125](/filings/0000357173-25-000091.md) | [6,006](/filings/0000357173-26-000045.md) | [5,956](/filings/0000357173-26-000022.md) | [5,967](/filings/0000357173-26-000045.md) |
| Shareholders' equity | $m | [533](/filings/0000357173-24-000075.md) | [577](/filings/0001104659-26-020393.md) | [596](/filings/0000357173-25-000076.md) | [619](/filings/0000357173-25-000091.md) | [661](/filings/0000357173-25-000091.md) | [671](/filings/0000357173-26-000045.md) | [694](/filings/0000357173-26-000045.md) | [719](/filings/0000357173-26-000045.md) | [867](/filings/0000357173-25-000091.md) | [897](/filings/0000357173-26-000045.md) | [893](/filings/0000357173-26-000045.md) | [903](/filings/0000357173-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [81.8 d](/filings/0000357173-24-000075.md) | [29.1 d](/filings/0001104659-26-020393.md) | [47.4](/filings/0000357173-25-000035.md) | [11.6 d](/filings/0000357173-25-000076.md) | [48.5 d](/filings/0000357173-25-000091.md) | [24.0 d](/filings/0001104659-26-020393.md) | [17.8](/filings/0000357173-26-000022.md) | [24.2 d](/filings/0000357173-26-000045.md) | [35.9 d](/filings/0000357173-25-000091.md) | [44.2 d](/filings/0001104659-26-020393.md) | [36.9](/filings/0000357173-26-000022.md) | [28.6 d](/filings/0000357173-26-000045.md) |
| Capital expenditure | $m | [5.2 d](/filings/0000357173-24-000075.md) | [4.2 d](/filings/0001104659-26-020393.md) | [3.3](/filings/0000357173-25-000035.md) | [3.0 d](/filings/0000357173-25-000076.md) | [2.3 d](/filings/0000357173-25-000091.md) | [2.1 d](/filings/0001104659-26-020393.md) | [1.6](/filings/0000357173-26-000022.md) | [0.8 d](/filings/0000357173-26-000045.md) | [1.2 d](/filings/0000357173-25-000091.md) | [0.9 d](/filings/0001104659-26-020393.md) | [0.8](/filings/0000357173-26-000022.md) | [0.7 d](/filings/0000357173-26-000045.md) |
| Dividends paid | $m | [2.2 d](/filings/0000357173-24-000075.md) | [2.2 d](/filings/0001104659-26-020393.md) | [2.2](/filings/0000357173-25-000035.md) | [2.2 d](/filings/0000357173-25-000076.md) | [2.2 d](/filings/0000357173-25-000091.md) | [2.7 d](/filings/0001104659-26-020393.md) | [2.7](/filings/0000357173-26-000022.md) | [2.7 d](/filings/0000357173-26-000045.md) | [3.2 d](/filings/0000357173-25-000091.md) | [3.7 d](/filings/0001104659-26-020393.md) | [3.7](/filings/0000357173-26-000022.md) | [3.6 d](/filings/0000357173-26-000045.md) |
| Share repurchases | $m | [0.0 d](/filings/0000357173-24-000075.md) | [0.0 d](/filings/0001104659-26-020393.md) | [0.8](/filings/0000357173-25-000035.md) | [0.0 d](/filings/0000357173-25-000076.md) | [0.0 d](/filings/0000357173-25-000091.md) | [0.3 d](/filings/0001104659-26-020393.md) | [1.4](/filings/0000357173-26-000022.md) | [0.1 d](/filings/0000357173-26-000045.md) | [5.9 d](/filings/0000357173-25-000091.md) | [0.0 d](/filings/0001104659-26-020393.md) | [24.5](/filings/0000357173-26-000022.md) | [15.8 d](/filings/0000357173-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.2](/filings/0000357173-23-000085.md) | [45.3](/filings/0000357173-24-000035.md) | [45.4](/filings/0000357173-24-000059.md) | [45.4](/filings/0000357173-24-000075.md) | [45.5](/filings/0000357173-25-000035.md) | [45.7](/filings/0000357173-25-000076.md) | [45.7](/filings/0000357173-25-000091.md) | [45.7](/filings/0000357173-26-000022.md) | [45.8](/filings/0000357173-26-000045.md) | [53.5](/filings/0000357173-25-000091.md) | [53.3](/filings/0000357173-26-000022.md) | [52.1](/filings/0000357173-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,875,716 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0000357173-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.